Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4–RD
Results support the [...] Read more »
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4–RD
Results support the [...] Read more »
Read more »
Read more »
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Read more »